Sue Gail Eckhardt - Net Worth and Insider Trading
Sue Gail Eckhardt Net Worth
The estimated net worth of Sue Gail Eckhardt is at least $1 Million dollars as of 2025-05-09. Sue Gail Eckhardt is the Director of Exelixis Inc and owns about 30,406 shares of Exelixis Inc (EXEL) stock worth over $1 Million. Details can be seen in Sue Gail Eckhardt's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sue Gail Eckhardt has not made any transactions after 2025-02-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sue Gail Eckhardt
Sue Gail Eckhardt Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sue Gail Eckhardt owns 1 companies in total, including Syros Pharmaceuticals Inc (SYRS) .
Click here to see the complete history of Sue Gail Eckhardt’s form 4 insider trades.
Insider Ownership Summary of Sue Gail Eckhardt
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| SYRS | Syros Pharmaceuticals Inc | 2020-09-08 | director |
Sue Gail Eckhardt Latest Holdings Summary
Sue Gail Eckhardt currently owns a total of 1 stock. Sue Gail Eckhardt owns 30,406 shares of Exelixis Inc (EXEL) as of February 14, 2025, with a value of $1 Million.
Latest Holdings of Sue Gail Eckhardt
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EXEL | Exelixis Inc | 2025-02-14 | 30,406 | 36.50 | 1,109,819 |
Holding Weightings of Sue Gail Eckhardt
Sue Gail Eckhardt Form 4 Trading Tracker
According to the SEC Form 4 filings, Sue Gail Eckhardt has made a total of 1 transactions in Exelixis Inc (EXEL) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Exelixis Inc is the sale of 11,568 shares on February 14, 2025, which brought Sue Gail Eckhardt around $405,111.
Insider Trading History of Sue Gail Eckhardt
- 1
Sue Gail Eckhardt Trading Performance
Sue Gail Eckhardt Ownership Network
Ownership Network List of Sue Gail Eckhardt
Ownership Network Relation of Sue Gail Eckhardt
Sue Gail Eckhardt Owned Company Details
What does Syros Pharmaceuticals Inc do?
Who are the key executives at Syros Pharmaceuticals Inc?
Sue Gail Eckhardt is the director of Syros Pharmaceuticals Inc. Other key executives at Syros Pharmaceuticals Inc include director & 10 percent owner & President & CEO Nancy A Simonian , Chief Legal Officer Gerald E Quirk , and Chief Medical Officer David Roth .
Syros Pharmaceuticals Inc (SYRS) Insider Trades Summary
Over the past 18 months, Sue Gail Eckhardt made no insider transaction in Syros Pharmaceuticals Inc (SYRS). Other recent insider transactions involving Syros Pharmaceuticals Inc (SYRS) include a net sale of 35,274 shares made by David Roth , a net sale of 171,783 shares made by Nancy A Simonian , and a net sale of 37,803 shares made by Jason Haas .
In summary, during the past 3 months, insiders sold 0 shares of Syros Pharmaceuticals Inc (SYRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 562,447 shares of Syros Pharmaceuticals Inc (SYRS) were sold and 1,104,977 shares were bought by its insiders, resulting in a net purchase of 542,530 shares.
Syros Pharmaceuticals Inc (SYRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Syros Pharmaceuticals Inc Insider Transactions
Sue Gail Eckhardt Mailing Address
Above is the net worth, insider trading, and ownership report for Sue Gail Eckhardt. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Sue Gail Eckhardt's mailing address is: Cambridge Ma 02140.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
